RECURRENT OVARY CANCER
Clinical trials for RECURRENT OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARY CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to tackle Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis early-phase study tests a new drug, DT2216, combined with the chemotherapy paclitaxel in people whose ovarian cancer has returned and is resistant to platinum-based treatments. The main goal is to find the safest dose of DT2216 when given with paclitaxel. About 30 participan…
Matched conditions: RECURRENT OVARY CANCER
Phase: PHASE1 • Sponsor: Elizabeth Stover, MD, PhD • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
Immune cell therapy takes on recurrent ovarian cancer
Disease control Recruiting nowThis early-phase study tests a new treatment called CIML NK cell therapy for people with recurrent ovarian cancer that no longer responds to platinum-based chemotherapy. The therapy uses specially trained natural killer cells from a donor to attack the cancer. The study aims to f…
Matched conditions: RECURRENT OVARY CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 18, 2026 11:59 UTC